Quick answer
Medline Inc. (MDLN) reported revenue of $28.43B and net income of $1.16B for the fiscal year ended 2025-12-31, up 11.5% from $25.51B the year before, per its 10-K filed with the SEC on 2026-02-25. Long-term debt stood at $12.48B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $28.43B | $1.16B | $12.48B |
| 2024 (FY ending 2024-12-31) | $25.51B | — | $16.42B |
| 2023 (FY ending 2023-12-31) | $23.23B | — | — |
Related
- MCO revenue, net income and debt history (Moody'S Corporation)
- MDB revenue, net income and debt history (Mongodb, Inc.)
- MDGL revenue, net income and debt history (Madrigal Pharmaceuticals, Inc.)
- MDLZ revenue, net income and debt history (Mondelez International, Inc.)
- MDT revenue, net income and debt history (Medtronic plc)
- MEDP revenue, net income and debt history (Medpace Holdings, Inc.)
- MELI revenue, net income and debt history (MercadoLibre, Inc.)
- MET revenue, net income and debt history (MetLife, Inc.)
Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.